| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.77B | 42.33B | 57.94B | 70.72B | 75.26B | 83.81B |
| Gross Profit | 6.85B | 7.83B | 11.44B | 12.05B | 13.61B | 12.91B |
| EBITDA | 2.70B | 3.56B | 6.77B | 7.12B | 8.03B | 7.67B |
| Net Income | 12.94B | 5.37B | 4.49B | 7.09B | 27.54B | 20.92B |
Balance Sheet | ||||||
| Total Assets | 256.30B | 149.94B | 126.61B | 89.08B | 89.87B | 74.65B |
| Cash, Cash Equivalents and Short-Term Investments | 13.68B | 20.83B | 28.06B | 20.72B | 25.77B | 21.41B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.79B |
| Total Liabilities | 66.77B | 31.70B | 23.94B | 14.54B | 22.44B | 24.60B |
| Stockholders Equity | 188.81B | 117.81B | 102.41B | 74.54B | 67.43B | 50.04B |
Cash Flow | ||||||
| Free Cash Flow | 4.04B | -6.03B | 7.22B | 452.31M | -983.37M | 4.86B |
| Operating Cash Flow | 5.91B | -3.73B | 8.16B | 1.24B | -195.28M | 5.51B |
| Investing Cash Flow | 14.79B | 3.59B | 214.06M | -5.52B | 20.02B | 17.02B |
| Financing Cash Flow | -18.46B | -7.51B | -5.39B | -1.74B | -16.53B | -18.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥163.64B | 2.91 | 1.86% | 0.76% | -18.07% | 156.03% | |
68 Neutral | ¥5.18T | 14.32 | -2.51% | 1.31% | 6.68% | -106.55% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥12.55B | -25.29 | ― | 1.86% | 0.55% | -198.36% | |
58 Neutral | ¥189.41B | -13.62 | ― | ― | -44.10% | -111.35% | |
57 Neutral | ¥21.31B | 15.70 | ― | 3.98% | -2.54% | 59.03% | |
49 Neutral | ¥1.37T | 47.56 | -4.26% | 2.30% | 3.51% | -490.72% |